we conclude that these patients are at risk for the development of abnormalities of the b-lymphocytic system , manifested by abnormal hyper-b-cell response in enlarged reactive lymph nodes and aggressive , extranodal b-cell lymphomas .
C0004561
b-cell
C0079731
b-cell lymphomas